CMMI Medicina Interna

Consejo Mexicano de Medicina Interna — Certificación en Medicina Interna (Mexico)

NeumologiaEnglish
Exam overview

Practice session

A 66-year-old man with a 45-pack-year smoking history presents with progressive exertional dyspnea and chronic morning cough productive of mucoid sputum. Post-bronchodilator spirometry demonstrates an FEV1/FVC ratio of 0.58 and an FEV1 of 62% of predicted value, confirming airflow limitation. His modified Medical Research Council (mMRC) dyspnea score is 2, and his COPD Assessment Test (CAT) score is 16. Over the past 12 months, he experienced zero moderate or severe exacerbations. According to the GOLD 2024 guidelines (ABE classification), which group does he belong to, and what is the recommended initial maintenance pharmacological therapy?

Loading your practice session…